Table 1.
Arbitrary case # | Diagnosis | Age | Sex | PMI | Notes |
---|---|---|---|---|---|
1 | Control | 47 | Male | 3 | – |
2 | Control | 60 | Male | 11 | – |
3 | Control | 68 | Female | 20 | – |
4 | Control | 76 | Female | 48 | – |
5 | Control | 89 | Female | 8 | – |
6 | Control | 90+ | Male | 23 | – |
7 | FTLD-tau | 33 | Male | 33 | P301L |
8 | FTLD-tau | 56 | Male | 26 | P301L; occipital tissue unavailable |
9 | FTLD-tau | 70 | Male | 12 | P301L |
10 | FTLD-tau | 71 | Female | 4 | Poor occipital staining |
11 | FTLD-tau | 71 | Female | 72 | – |
12 | FTLD-tau | 98 | Female | NA | – |
13 | CBD | 64 | Male | 18 | Frontal tissue unavailable |
14 | CBD | 67 | Female | 17 | – |
15 | CBD | 71 | Male | 18 | – |
16 | CBD | 74 | Male | 18 | – |
17 | CBD | 80 | Male | 12 | – |
18 | PSP | 49 | Male | 24 | Poor occipital staining |
19 | PSP | 79 | Male | 4 | – |
20 | PSP | 79 | Male | 10 | – |
21 | PSP | 81 | Female | 16 | – |
22 | PSP | 94 | Female | 24 | – |
CBD, corticobasal degeneration; FTLD-tau, frontotemporal lobar degeneration-tau; NA, not available; PMI, post-mortem interval (in hours); PSP, progressive supranuclear palsy.